Search Results - "Landersdorfer, C"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii by Smith, N.M., Lenhard, J.R., Boissonneault, K.R., Landersdorfer, C.B., Bulitta, J.B., Holden, P.N., Forrest, A., Nation, R.L., Li, J., Tsuji, B.T.

    Published in Clinical microbiology and infection (01-09-2020)
    “…Increased rates of carbapenem-resistant strains of Acinetobacter baumannii have forced clinicians to rely upon last-line agents, such as the polymyxins, or…”
    Get full text
    Journal Article
  2. 2

    Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers by BULITTA, J. B, LANDERSDORFER, C. B, HILTTNER, S. J, DRUSANO, G. L, KINZIG, M, HOLZGRABE, U, STEPHAN, U, SÖRGEL, F

    Published in Antimicrobial Agents and Chemotherapy (01-03-2010)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Evaluation of enrofloxacin use in koalas (Phascolarctos cinereus) via population pharmacokinetics and Monte Carlo simulation by Black, L. A, Landersdorfer, C. B, Bulitta, J. B, Griffith, J. E, Govendir, M

    “…Clinically normal koalas (n = 6) received a single dose of intravenous enrofloxacin (10 mg/kg). Serial plasma samples were collected over 24 h, and…”
    Get full text
    Journal Article
  4. 4

    Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers by BULITTA, J. B, KINZIG, M, LANDERSDORFER, C. B, HOLZGRABE, U, STEPHAN, U, SÖRGEL, F

    Published in Antimicrobial Agents and Chemotherapy (01-06-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics by BULITTA, J. B, LANDERSDORFER, C. B, KINZIG, M, HOLZGRABE, U, SORGEL, F

    Published in Antimicrobial Agents and Chemotherapy (01-08-2009)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis by Sandri, Ana M, Landersdorfer, Cornelia B, Jacob, Jovan, Boniatti, Márcio M, Dalarosa, Micheline G, Falci, Diego R, Behle, Tainá F, Saitovitch, David, Wang, Jiping, Forrest, Alan, Nation, Roger L, Zavascki, Alexandre P, Li, Jian

    Published in Journal of antimicrobial chemotherapy (01-03-2013)
    “…To evaluate the pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis (CVVHD) after intravenous administration of unadjusted…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics and pharmacodynamics of antibiotics in intensive care by Sörgel, F, Höhl, R, Glaser, R, Stelzer, C, Munz, M, Vormittag, M, Kinzig, M, Bulitta, J, Landersdorfer, C, Junger, A, Christ, M, Wilhelm, M, Holzgrabe, U

    “…Optimized dosage regimens of antibiotics have remained obscure since their introduction. During the last two decades pharmacokinetic(PK)-pharmacodynamic(PD)…”
    Get full text
    Journal Article
  8. 8

    Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa by Rees, Vanessa E, Bulitta, Jürgen B, Nation, Roger L, Tsuji, Brian T, Sörgel, Fritz, Landersdorfer, Cornelia B

    Published in Journal of antimicrobial chemotherapy (01-03-2015)
    “…For fluoroquinolones, the area under the free plasma concentration-time curve divided by the MIC (fAUC/MIC) best predicts bacterial killing in mice and…”
    Get full text
    Journal Article
  9. 9

    Evaluation of enrofloxacin use in koalas ( P hascolarctos cinereus ) via population pharmacokinetics and M onte C arlo simulation by Black, L. A., Landersdorfer, C. B., Bulitta, J. B., Griffith, J. E., Govendir, M.

    “…Clinically normal koalas ( n  = 6) received a single dose of intravenous enrofloxacin (10 mg/kg). Serial plasma samples were collected over 24 h, and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    First-Dose Pharmacokinetics of Lithium Carbonate in Children and Adolescents by FINDLING, Robert L, LANDERSDORFER, Cornelia B, FABER, Jon, TAYLOR-ZAPATA, Perdita, JUSKO, William J, KAFANTARIS, Vivian, PAVULURI, Mani, MCNAMARA, Nora K, MCCLELLAN, Jon, FRAZIER, Jean A, SIKICH, Linmarie, KOWATCH, Robert, LINGLER, Jacqui

    Published in Journal of clinical psychopharmacology (01-08-2010)
    “…This study examines the pharmacokinetics of oral doses of lithium carbonate immediate-release capsules after administration of 600 or 900 mg in children and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin by Sörgel, F., Höhl, R., Glaser, R., Stelzer, C., Munz, M., Vormittag, M., Kinzig, M., Bulitta, J., Landersdorfer, C., Junger, A., Christ, M., Wilhelm, M., Holzgrabe, U.

    “…Zusammenfassung Die optimale Dosierung von Antibiotika ist seit ihrer Einführung unklar geblieben. In den letzten 20 Jahren wurden 3…”
    Get full text
    Journal Article